Opinion: Predicting the Efficacy of Cancer Immunotherapy

by Jacob Richards,  TheScientist

Cancer therapy has blossomed in the last decade with more than 185 US Food and Drug Administration (FDA)-approved drugs on the market, including multiple therapies targeting the immune system. The immune system is the body’s main defense against any malignancy, including cancer.  However, most cancers have developed ways to evade the immune system by suppressing or hiding from it. Recently, researchers have begun to devise ways to turn the immune system back “on” in cancer, known as cancer immunotherapy.  Read the entire story.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s